Available datapackage for study 'A Randomized, Double-Blind, Parallel Group, Active Controlled, Multi-center Long-term Study to Assess the Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) 50 mg qd and 100 mg qd in Subjects With Symptoms of Overactive Bladder'

Name: Available datapackage for study 'A Randomized, Double-Blind, Parallel Group, Active Controlled, Multi-center Long-term Study to Assess the Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) 50 mg qd and 100 mg qd in Subjects With Symptoms of Overactive Bladder'
Creator: Vivli
Published: 2026-04-17 18:09:56
License: 暂无描述

DataCite Commons2026-04-17 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00010593.0

下载链接

链接失效反馈

官方服务：

资源简介：

The study is intended to test the safety, tolerability, efficacy of two doses of long term once daily (qd) treatment of Mirabegron in patients with symptoms of overactive bladder and secondly to compare these with active comparator.

提供机构：

Vivli

创建时间：

2026-04-17